Axon Enterprise, Inc $AXON Stock Holdings Boosted by EverSource Wealth Advisors LLC

Posted by Brian Himes on Aug 14th, 2026

EverSource Wealth Advisors LLC lifted its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 111.2% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 3,666 shares of the biotechnology company’s stock after buying an additional 1,930 shares during the period. EverSource Wealth Advisors LLC’s holdings in Axon Enterprise were worth $2,055,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the company. Edgewood Management LLC acquired a new stake in Axon Enterprise in the 4th quarter valued at about $846,516,000. Wellington Management Group LLP lifted its stake in Axon Enterprise by 326.9% during the fourth quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after purchasing an additional 1,179,038 shares during the last quarter. Norges Bank acquired a new position in Axon Enterprise in the fourth quarter worth approximately $515,764,000. Styrax Capital LP bought a new position in shares of Axon Enterprise in the first quarter valued at $84,938,000. Finally, Sands Capital Management LLC lifted its position in shares of Axon Enterprise by 11.6% during the 4th quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock valued at $914,047,000 after acquiring an additional 167,095 shares during the last quarter. 79.08% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Axon Enterprise news, CEO Patrick W. Smith sold 9,930 shares of the stock in a transaction on Friday, August 7th. The shares were sold at an average price of $548.77, for a total transaction of $5,449,286.10. Following the transaction, the chief executive officer directly owned 3,031,067 shares of the company’s stock, valued at $1,663,358,637.59. This represents a 0.33% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 13,000 shares of the company’s stock in a transaction dated Friday, June 5th. The stock was sold at an average price of $488.45, for a total value of $6,349,850.00. Following the sale, the president owned 169,125 shares of the company’s stock, valued at approximately $82,609,106.25. This trade represents a 7.14% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 68,989 shares of company stock valued at $36,016,932. 4.20% of the stock is owned by company insiders.

Analyst Ratings Changes

A number of equities analysts recently issued reports on AXON shares. TD Cowen restated a “buy” rating on shares of Axon Enterprise in a report on Wednesday, July 22nd. Zacks Research downgraded Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Friday, July 10th. Barclays raised their target price on shares of Axon Enterprise from $523.00 to $688.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Piper Sandler boosted their price target on shares of Axon Enterprise from $724.00 to $732.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Finally, Morgan Stanley raised their price objective on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research note on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus target price of $730.92.

Read Our Latest Research Report on AXON

Axon Enterprise Price Performance

Shares of NASDAQ:AXON opened at $615.59 on Friday. The firm has a market cap of $50.01 billion, a price-to-earnings ratio of 255.43, a P/E/G ratio of 12.24 and a beta of 1.39. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $794.29. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The business has a fifty day simple moving average of $523.52 and a 200 day simple moving average of $473.43.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last posted its quarterly earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The business’s quarterly revenue was up 35.3% on a year-over-year basis. During the same period last year, the business earned $2.12 EPS. As a group, sell-side analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

Positive Sentiment: Strong Q2 results and raised outlook: Axon exceeded expectations with adjusted earnings of $1.88 per share versus $1.84 expected and revenue of $904.4 million versus $876.4 million expected. Revenue grew 35.3% year over year, and management’s improved outlook supports the long-term growth story. Should You Buy, Hold or Sell AXON Stock Post Q2 Earnings Release?
Positive Sentiment: Connected Devices momentum: TASER devices, body cameras and counter-drone products are driving strong hardware demand. Continued adoption of these products, combined with Axon’s cloud-based evidence and records software, reinforces the company’s integrated platform strategy. Will Strength in Connected Devices Unit Continue to Drive AXON’s Growth?
Positive Sentiment: Bullish strategic commentary: Analysts highlighted Axon as a strong contender in law-enforcement technology, while coverage pointed to new artificial-intelligence capabilities as an additional growth catalyst for public-safety customers. Axon: A Strong Contender in Law Enforcement Tech
Neutral Sentiment: Technical consolidation: AXON remains in a strong broader uptrend but has recently consolidated, leaving investors watching whether momentum resumes or the rally pauses. Stock of the Day: Is the Axon Rally Over?
Negative Sentiment: Valuation and profitability risks: Despite strong revenue growth, analysts cautioned that Axon’s high earnings multiple, elevated costs, debt and relatively modest margins reduce its near-term appeal. Memory costs and counter-drone investments could also pressure profitability if spending rises faster than sales.
Negative Sentiment: CEO share sale: CEO Patrick Smith sold 9,930 shares worth approximately $5.45 million. The transaction occurred under a pre-arranged Rule 10b5-1 plan and represented only 0.33% of his holdings, making it a limited signal but a potential source of investor caution.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.